Houte Hans Van
Chief Financial Officer · 6 filings · Latest: Aug 4, 2026
Nurix Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
NRIX | Houte Hans Van | Chief Financial Officer | Aug 4, 2026 | Sale | $24.36 | 4,761 | $116.0K | 40,166 | |
NRIX | JOHANNES VAN HOUTE | — | Aug 4, 2026 | Proposed Sale | $23.22 | 4,761 | $110.6K | — | |
NRIX | Houte Hans Van | Chief Financial Officer | Jul 30, 2026 | Sale | $23.38 | 2,845 | $66.5K | 44,927 | |
NRIX | Houte Hans Van | Chief Financial Officer | Jul 30, 2026 | Option Exercise | $0.00 | 10,180 | — | 47,772 | |
NRIX | Houte Hans Van | Chief Financial Officer | May 5, 2026 | Sale | $16.60 | 14,055 | $233.3K | 37,592 | |
NRIX | JOHANNES VAN HOUTE | — | May 5, 2026 | Proposed Sale | $16.93 | 14,055 | $238.0K | — | |
NRIX | Houte Hans Van | Chief Financial Officer | Apr 30, 2026 | Sale | $16.65 | 2,388 | $39.7K | 51,647 | |
NRIX | Houte Hans Van | Chief Financial Officer | Apr 30, 2026 | Option Exercise | $0.00 | 8,608 | — | 54,035 | |
NRIX | Houte Hans Van | Chief Financial Officer | Jan 30, 2026 | Sale | $16.60 | 3,661 | $60.8K | 45,427 | |
NRIX | Houte Hans Van | Chief Financial Officer | Jan 30, 2026 | Option Exercise | $0.00 | 11,496 | — | 49,088 | |
NRIX | JOHANNES VAN HOUTE | — | Nov 3, 2025 | Proposed Sale | $12.94 | 6,284 | $81.3K | — | |
NRIX | JOHANNES VAN HOUTE | — | May 2, 2025 | Proposed Sale | $11.16 | 6,198 | $69.2K | — | |
NRIX | JOHANNES VAN HOUTE | — | Mar 3, 2025 | Proposed Sale | $15.45 | 5,825 | $90.0K | — | |
NRIX | JOHANNES VAN HOUTE | — | Nov 1, 2024 | Proposed Sale | $24.58 | 3,546 | $87.2K | — | |
NRIX | JOHANNES VAN HOUTE | — | Aug 26, 2024 | Proposed Sale | $24.02 | 20,000 | $480.4K | — | |
NRIX | JOHANNES VAN HOUTE | — | Aug 1, 2025 | Proposed Sale | $11.26 | 5,402 | $60.8K | — |